Navigation Links
Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
Date:8/1/2008

SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the BMO Capital Markets 2008 Focus on Healthcare Conference on Tuesday, August 5, at 11:15 a.m. Eastern Time at the Millennium Broadway Hotel in New York.

Dr. Hung will provide an overview of Medivation and its clinical development programs for Dimebon for Alzheimer's and Huntington's diseases and MDV3100 for prostate cancer.

A live audio webcast of the presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the positive results seen in its Phase 2 trial. For more information, please visit us at http://www.medivation.com. '/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
2. Medivation Announces Senior Management Promotions
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
6. Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
7. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
8. Novavax Announces Closing of $18 Million Registered Direct Offering
9. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
10. Thermage, Inc. Announces Second Quarter 2008 Results Release Date and Conference Call
11. deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TS...erofadvancedlasersystemsandinstrumentsforthestemce...perationalandfinancialresultsforthethirdquarterend...was$1.46millioncomparedwith$1.43millioninQ32008,-G...entinQ3,2008,-Netlossreducedto$148,000comparedto$2...
(Date:11/24/2009)...ire/--HealthRoboticstodayannounced,thatithasformed...tors.ThisrecentlyformedToronto-basedcompanywillope...arket,install,andsupport,HealthRobotics,i.v.Roomof...ductofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(T...nceonan"asneeded,basis"toitsstrategicpartnershipsw...
(Date:11/23/2009)... provocative new study, a University of Utah scien...the major cause of global warming cannot be stabi...ety builds the equivalent of one new nuclear power...e will be any substantial near-term departure from...emission rates," says the new paper by Tim Garrett...
(Date:11/23/2009)...ewswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq:...ber27,2009astheex-dividenddateforits$200millionspe...zationtransactioncompletedonNovember2,2009.Thedivi...recordontherecorddate,December1,2009.NASDAQhassett...shareofcommonstockforpurposesoftheex-dividenddateo...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...VANCOUVER, June 9 /PRNewswire/ - OncoGenex Technol...th Annual Biotechnology & Medical,Technology Confe...ce Hotel.,OncoGenex, President and Chief Executive...overview at the conference, including an overview ...om the American Society of,Clinical Oncology (ASCO...
...NEW YORK and LONDON, June 9 Paul Capital Healthca...acleod, Ph.D., will moderate,a panel on strategic ...nnovate Europe 08 conference. Designed to familiar...s a strategic approach to financing, the panel,"Fe... Strategy for Meeting,Biotechnology,s Capital Need...
...A Powerful New Tool for Early Identification of Hi...Help Prevent Disease Progression, SAN FRANCISCO, ... the 68th Scientific Sessions of the American Diab...ailability of its novel PreDx(TM) Diabetes,Risk Te...ers an accurate,assessment of an individual,s risk...
Other Biology Technology:OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 2OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 3Paul Capital Healthcare Leads Panel on Strategic Financing 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 3Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 4
(Date:11/23/2009)...009 -- A USDOE and USDA study concluded that 50 mi...ropland pasture could be converted from current us... switchgrass, from which biomass could be harveste...ble production of a perennial grass monoculture fr...oved annually is expected to require nitrogen fert...
(Date:11/23/2009)...of New Hampshire microbiologist Louis Tisa has rec...rstanding of the actinorhizal plants, widespread w... and contaminated soils. , The United States De...fessor of molecular, cellular and biomedical scien...p between the bacteria Frankia and Casuarina, an a...
(Date:11/23/2009)...lifornia biomedical engineer and cardiologist Tzun... clinicians distinguish cardiac emergencies requir...able with drugs and lifestyle change. , Angiogra...eries feeding the heart, offer an inside view of t...ls, often revealing deposits of a dangerous fatty ...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Nature parks can save species as climate changes 12401 1Nature parks can save species as climate changes 12401 2Nature parks can save species as climate changes 12401 3AIAA names top ten emerging aerospace technologies of 2009 12399 1AIAA names top ten emerging aerospace technologies of 2009 12399 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 1Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 3
...ope and the California Department of Public Health...ct botulinum neurotoxin. The toxin is one of the m...-threatening disease, and is considered a major po...eams work is published today in the online journal...1 ). , Botulinum neurotoxin is produced by the ...
... mouse model of gastritis and stomach cancer, rese...logy (MIT) say that prompt treatment of Helicobact...o the lining of the stomach that can lead to cance...rnal of the American Association for Cancer Resear... to rest any question about whether and when - a...
...ates Patent and Trademark Office (USPTO) today rej... bean that has been a familiar staple in Latin Ame... was erroneously granted patent protection in 1999...ised profound concerns about biopiracy and the pot...on plant materials that originate in the developin...
Other Biology News:Researchers develop new ultrasensitive assay to detect most poisonous substance known 2Early treatment of stomach infection may prevent cancer 2Early treatment of stomach infection may prevent cancer 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 2US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 4
... Protein Precipitation Kit is designed for concent...es. Proteomics sample analysis is often hampered b...uffers, salts and detergents in the protein sample...r enzymatic digestion. Additionally, proteins in s...
...activated carrier proteins to simplify the product... Activated Carrier Proteins are commonly used carr...nctional cross-linker (Sulfo-SMCC). This activatio... protein. Thus allowing the maleimide-activated c...
...d, convenient, and efficient native protein concen... process utilizes a spin column to make handling e...ins which were electro-eluted in their native cond...ng high binding capacity fo all pH values. Minimum...
...cally clear polystyrene with frosted labeling surf...tes for cell counting. 100% integrity tested. Link...ted to easily match Cornings product number. If sh...old Sigma-Aldrich number (Z71,693-6) or contact cu...
Biology Products: